View Message in Browser

[link removed]

 

[link removed]

 

[link removed]

 

[link removed]

 

mailto:[email protected]

[link removed]

**Thursday, November 19, 2020**

[link removed]

[link removed]

Today, Health Affairs is focusing special coverage on COVID-19 vaccines
and treatment
.

Amidst the recent news of successful vaccine trials and new treatments,
we shine a light on the policy and regulatory issues that must be
addressed.

This set of fast-track ahead-of-print journal articles kicks off with a
broad overview of the US Food and Drug Administration (FDA) approval
process

by Aaron Kesselheim and colleagues. The paper explores vaccine
development, approval, and regulation as well as trade-offs in balancing
safety, efficacy, and speed.

New research released today asks the question: How successful will newly
emerging vaccines be in stemming the pandemic?

Different combinations of vaccine characteristics, effectiveness, pace
of distribution, and "background epidemic severity" can affect
infection rates, hospitalizations, and mortality. While more effective
vaccines always lead to better outcomes, the story gets more complex
when you start to vary the parameters. David Paltiel and Jason Schwartz
from the Yale University School of Public Health and Amy Zheng and
Rochelle Walensky from Harvard Medical School walk us through the
variables.

Three analytic papers review key policy questions such as why we must
invest in vaccine delivery strategies; how public and private leaders
can ensure equitable access; and what to consider in pricing vaccines
and treatments.

* Delivery strategies
:
Rebecca Weintraub of Adriadne Labs and colleagues analyze why leaders
must invest in vaccine delivery strategies now. This paper offers
recommendations for policy makers and looks at past pandemics and
vaccine campaigns to offer lessons on successful vaccine delivery.

* Equity
:
Angela Shen of Children's Hospital of Philadelphia and colleagues
offer recommendations to public and private leaders to help ensure
equitable access to all who are recommended for vaccination, regardless
of ability to pay, where people live, or historic or systemic
limitations to health care.

* Pricing
:
In this broad look at pricing, authors Peter Neumann of Tufts University
Medical School and colleagues shed light on solutions to the "policy
puzzle" of balancing lower prices to ensure access to essential
medications, vaccines, and tests, while also ensuring adequate revenue
streams to provide manufacturers incentives to make the substantial,
risky investments needed to develop products in the first place.

In preparation for publishing these peer-reviewed papers today, Health
Affairs brought researchers, industry leaders, and advocates together at
an August 2020 symposium (available online) to discuss promoting vaccine
and treatment innovation and equity
.

Reporter Harris Meyer summarized the event in this month's EntryPoint
in Health Affairs, noting themes of collaboration and competition
.

Health Affairs is grateful to the theme advisers, Helen Saxenian and
Jason Schwartz, and to the following sponsors for their support of this
fast-track publication and the symposium: Anthem, Inc.; Amgen Inc.;
Avalere; Kaiser Permanente; Pharmaceutical Research and Manufacturers of
America (PhRMA); Gilead; McKesson; Quest Diagnostics; Dynavax; Alexion;
and Danaher.

Read More 

[link removed]

 

[link removed]

 

[link removed]

 

[link removed]

About Health Affairs

Health Affairs is the leading peer-reviewed journal
at the intersection of health,
health care, and policy. Published monthly by Project HOPE, the journal
is available in print and online. Late-breaking content is also found
through healthaffairs.org , Health Affairs
Today , and Health Affairs
Sunday Update .  

Project HOPE is a global health and
humanitarian relief organization that places power in the hands of local
health care workers to save lives across the globe. Project HOPE has
published Health Affairs since 1981.

Copyright © Project HOPE: The People-to-People Health Foundation, Inc.

Health Affairs, 7500 Old Georgetown Road, Suite 600, Bethesda, MD 20814, United States

Privacy Policy

To unsubscribe from this email, click here
.                 
                                               
                        I
_________________

Sent to [email protected]

Unsubscribe:
[link removed]

Health Affairs, 7500 Old Georgetown Road, Suite 600, Bethesda, MD 20814, United States